CLRB Cellectar Biosciences, Inc.
NEUTRAL
Impact: 2/10
PRESS-RELEASE
Press release: earnings
Latest settled — T+5d
CLRB ▲ +2.61% at T+5d
NEUTRAL call ✓ call won +2.61% · α vs SPY +2.70% · entry $3.06 → $3.14
Currently $2.36 · -22.88% from $3.06 entry
T+1d
-4.58%
call -4.58% · α -4.44%
$2.92
settled 29d ago
T+5d
+2.61%
call +2.61% · α +2.70%
$3.14
settled 23d ago
T+20d
—
call — · α —
—
due 15h ago
T+60d
—
call — · α —
—
in 8w
Price Chart
Loading chart...
Executive Summary
Cellectar Biosciences announced it will report Q1 2026 financial results on May 14, 2026, with no actual financial data disclosed in this press release. The release is purely an earnings date announcement with no operational or financial updates.
Actionable Insight
This is a routine earnings date announcement with no material information. Monitor the May 14 earnings call for updates on iopofosine I 131 trial progress and cash runway, which are the key catalysts for this micro-cap biotech.
Key Facts
- Q1 2026 earnings release scheduled for May 14, 2026 at 8:30 AM ET
- No financial results or operational updates provided in this press release
- Company is a late-stage clinical biopharmaceutical firm focused on cancer treatments
Financial Impact
No financial data disclosed in this filing
Risk Factors
- No financial or operational data provided in this filing
- Micro-cap biotech with high cash burn risk typical of clinical-stage companies
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291850 |
14 reports for CLRB
75%
Hit rate
best @ T+20▲ +26.35%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
Press Release
| $2.97 $2.59 | ▼ −12.79% | ▼ −10.04% | $2.36 (−20.54%) |
|
May 29, 2026
11d ago
|
S-1/A
| $3.14 $2.60 | ▲ +17.20% | ▲ +16.90% | $2.36 (+24.84%) |
|
May 28, 2026
12d ago
|
DEFA14A
| $3.14 $2.59 | ▼ −17.52% | ▼ −15.02% | $2.36 (−24.84%) |
|
May 19, 2026
21d ago
|
S-1
| $3.17 $3.14 | ▲ +0.95% | ▲ +2.18% | $2.36 (+25.55%) |
|
May 14, 2026
26d ago
|
8-K
| $3.20 $3.17 | ▼ −0.94% | ▼ −0.22% | $2.36 (−26.25%) |
|
May 14, 2026
26d ago
|
Press Release
| $3.20 $3.17 | ▼ −0.94% | ▼ −0.22% | $2.36 (−26.25%) |
|
May 11, 2026
29d ago
|
Press Release
| $3.06 $3.14 | ▲ +2.61% | ▲ +2.70% | $2.36 (−22.88%) |
|
May 8, 2026
4w ago
|
8-K
| $3.10 $3.20 | ▼ −3.23% | ▼ −1.76% | $2.36 (+23.87%) |
|
May 7, 2026
4w ago
|
Insider Cluster
| $3.30 $2.94 | ▲ +10.91% | ▲ +12.41% | $2.36 (+28.48%) |
|
May 6, 2026
4w ago
|
424B5
| $3.53 $2.92 | ▲ +17.28% | ▲ +18.41% | $2.36 (+33.14%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Thu (10h 8m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access